Veedma offers free doctor review of recent men's lab work and $59 testosterone panel

Veedma is giving men with blood work from the past 180 days a free written doctor review and offering a $59 65-biomarker panel for new testing. The San Francisco telehealth clinic says both options aim to distinguish low testosterone from other causes of symptoms before treatment is considered.

Why it matters: - Veedma is trying to reduce guesswork in men’s hormone care by starting with lab diagnostics before any treatment or membership decision. - The approach could help men avoid being routed directly to testosterone therapy when symptoms are caused by thyroid disease, insulin resistance, iron deficiency, low vitamin D or sleep disorders instead. - The clinic is also making initial evaluation cheaper, with a free review for men who already have recent labs and a low-cost panel for men who need new testing.

What happened: - Veedma, a preventive telehealth clinic focused on hormone and sexual health, is offering men with blood work drawn in the past 180 days a free written doctor review. - Men can upload results from any U.S. lab at more information for a clinical review with no credit card required. - New patients can order a first Men's Optimal Health Lab Test for $59, down from a regular price of $89. - Veedma also offers a Men's Biohacking Lab Test for $409.

The details: - A licensed doctor reviews uploaded lab results together with symptoms and medical history, then returns a written report in patient chat. - Veedma says the free review usually arrives within 24 hours on business days and within 48 hours on weekends and holidays. - The $59 Men's Optimal Health Lab Test covers 65 biomarkers. - The panel includes total and free testosterone measured by LC-MS/MS with equilibrium dialysis, estradiol, LH, FSH, PSA, complete blood count, liver, kidney and electrolyte panels, lipid panel and fasting glucose. - The $409 Men's Biohacking Lab Test covers 103 biomarkers. - That larger panel adds thyroid function and antibodies, fasting insulin and HbA1c, ApoB, hsCRP, iron studies, vitamin D, B12, prolactin, DHEA-S and heavy metals. - Both panel prices include the blood draw at Quest Diagnostics and the written clinical review in patient chat. - The lab panels are FSA and HSA eligible. - Veedma says it starts care with laboratory testing for two reasons: differential diagnosis and treatment selection. - The clinic says morning total and free testosterone, plus pituitary hormones luteinizing hormone and follicle-stimulating hormone, help show whether the testes are failing or whether the upstream signal is reduced. - Veedma cites the European Male Ageing Study, published in the Journal of Clinical Endocrinology and Metabolism in 2010, and says about 86% of men with low testosterone had the second pattern. - In those cases, Veedma says care can focus on underlying or reversible contributors such as excess weight, thyroid or prolactin disorders, or a suppressing medication. - Veedma says exogenous testosterone can reduce the body’s own signal and sperm production.

Between the lines: - The pricing suggests Veedma is positioning itself as an entry point for men who want a faster, lower-friction path to evaluation than a traditional specialist workup. - The lab-first model also gives Veedma a built-in filter before prescribing, which may appeal to patients worried about overdiagnosis or premature treatment. - The company is leaning on clinical interpretation and biomarker breadth as the main differentiators rather than on symptom-checking alone.

What's next: - If the clinical report identifies a treatment path, the patient can choose a flat-price membership and schedule a video visit with a licensed doctor. - The saved payment card is charged only if the doctor issues a prescription. - Membership pricing is $79 per month on an annual plan, $129 per month on a quarterly plan or $159 per month with no commitment. - Membership includes the video visit, prescribed daily medication, delivery from Veedma's NABP-accredited partner pharmacy, ongoing messaging with the care team and follow-up lab reviews and dose adjustments. - Follow-up labs are checked after the first month of treatment and every six months after that. - Monitoring includes hematocrit and PSA in line with American Urological Association, American Association of Clinical Endocrinology and Endocrine Society guidelines. - Veedma says it is LegitScript-certified and describes itself as a preventive telehealth clinic for hormone and sexual health. - More information is available the company's announcement and low-testosterone details.